Revolutionary limb saving procedure set to benefit patients with Chronic Limb-Threatening Ischemia, typically caused by Type 2 Diabetes
SINGAPORE -
Media OutReach - 15 September 2023 -
M&L Healthcare, in its first major MedTech investment, has announced that the U.S.
Read more: M&L Healthcare's First MedTech Investment Receives FDA Approval Following Successful US Trials